Hamartoma risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
==References== | ==References== | ||
{{reflist| | {{reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 17:59, 26 January 2016
|
Hamartoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hamartoma risk factors On the Web |
|
American Roentgen Ray Society Images of Hamartoma risk factors |
|
Risk calculators and risk factors for Hamartoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
The most potent risk factor in the development of hamartomas is familial hamartomatous syndromes.[1]
Risk factors
- The most potent risk factor in the development of hamartomas is familial hamartomatous syndromes.
- Risk factors associated with hamartomatous formation, include:[2]
- Juvenile polyposis syndrome
- Peutz-Jeghers syndrome
- Hereditary mixed polyposis syndrome
- PTEN hamartoma tumour syndrome
- Tuberous sclerosis
- Cowden’s syndrome
- Bannayan-Riley-Ruvalcaba syndrome
References
- ↑ Richardson MS (2016). "Familiar and unfamiliar pseudoneoplastic lesions of the head and neck". Semin Diagn Pathol. 33 (1): 24–30. doi:10.1053/j.semdp.2015.09.004. PMID 26739631.
- ↑ Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z; et al. (1997). "Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome". Nat Genet. 16 (1): 64–7. doi:10.1038/ng0597-64. PMID 9140396.